These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 11091773

  • 1. Measuring medication adherence: are missed doses reported more accurately then perfect adherence?
    Wagner GJ, Rabkin JG.
    AIDS Care; 2000 Aug; 12(4):405-8. PubMed ID: 11091773
    [Abstract] [Full Text] [Related]

  • 2. Factors associated with accurate self-reported adherence to HIV antiretrovirals.
    Kimmerling M, Wagner G, Ghosh-Dastidar B.
    Int J STD AIDS; 2003 Apr; 14(4):281-4. PubMed ID: 12716500
    [Abstract] [Full Text] [Related]

  • 3. 'Simply forgot' is the most frequently stated reason for missed doses of HAART irrespective of degree of adherence.
    Barfod TS, Sørensen HT, Nielsen H, Rodkjaer L, Obel N.
    HIV Med; 2006 Jul; 7(5):285-90. PubMed ID: 16945072
    [Abstract] [Full Text] [Related]

  • 4. Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana.
    Vriesendorp R, Cohen A, Kristanto P, Vrijens B, Rakesh P, Anand B, Iwebor HU, Stiekema J.
    Eur J Clin Pharmacol; 2007 Dec; 63(12):1115-21. PubMed ID: 17882408
    [Abstract] [Full Text] [Related]

  • 5. Medication adherence in patients with HIV infection: a comparison of two measurement methods.
    Melbourne KM, Geletko SM, Brown SL, Willey-Lessne C, Chase S, Fisher A.
    AIDS Read; 1999 Aug; 9(5):329-38. PubMed ID: 12737122
    [Abstract] [Full Text] [Related]

  • 6. Long-term utility of measuring adherence by self-report compared with pharmacy record in a routine clinic setting.
    Fairley CK, Permana A, Read TR.
    HIV Med; 2005 Sep; 6(5):366-9. PubMed ID: 16156886
    [Abstract] [Full Text] [Related]

  • 7. Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients.
    Glass TR, De Geest S, Hirschel B, Battegay M, Furrer H, Covassini M, Vernazza PL, Bernasconi E, Rickenboch M, Weber R, Bucher HC, Swiss HIV Cohort Study.
    Antivir Ther; 2008 Sep; 13(1):77-85. PubMed ID: 18389901
    [Abstract] [Full Text] [Related]

  • 8. A randomized comparison of two instruments for measuring self-reported antiretroviral adherence.
    Mannheimer S, Thackeray L, Huppler Hullsiek K, Chesney M, Gardner EM, Wu AW, Telzak EE, Lawrence J, Baxter J, Friedland G, Terry Beirn Community Program for Clinical Research on AIDS.
    AIDS Care; 2008 Feb; 20(2):161-9. PubMed ID: 18293124
    [Abstract] [Full Text] [Related]

  • 9. Adherence to directly observed antiretroviral therapy among human immunodeficiency virus-infected prison inmates.
    Wohl DA, Stephenson BL, Golin CE, Kiziah CN, Rosen D, Ngo B, Liu H, Kaplan AH.
    Clin Infect Dis; 2003 Jun 15; 36(12):1572-6. PubMed ID: 12802758
    [Abstract] [Full Text] [Related]

  • 10. How late is too late? Timeliness to scheduled visits as an antiretroviral therapy adherence measure in Nairobi, Kenya and Lusaka, Zambia.
    Blacher RJ, Muiruri P, Njobvu L, Mutsotso W, Potter D, Ong'ech J, Mwai P, Degroot A, Zulu I, Bolu O, Stringer J, Kiarie J, Weidle PJ.
    AIDS Care; 2010 Nov 15; 22(11):1323-31. PubMed ID: 20711886
    [Abstract] [Full Text] [Related]

  • 11. Patient and regimen characteristics associated with self-reported nonadherence to antiretroviral therapy.
    Sullivan PS, Campsmith ML, Nakamura GV, Begley EB, Schulden J, Nakashima AK.
    PLoS One; 2007 Jun 20; 2(6):e552. PubMed ID: 17579723
    [Abstract] [Full Text] [Related]

  • 12. Validity of a stage of change instrument in assessing medication adherence in indigent patients with HIV infection.
    Rathbun RC, Farmer KC, Lockhart SM, Stephens JR.
    Ann Pharmacother; 2007 Feb 20; 41(2):208-14. PubMed ID: 17213294
    [Abstract] [Full Text] [Related]

  • 13. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K.
    Verh K Acad Geneeskd Belg; 2001 Feb 20; 63(5):447-73. PubMed ID: 11813503
    [Abstract] [Full Text] [Related]

  • 14. Utility of the Millon Behavioral Medicine Diagnostic (MBMD) to predict adherence to highly active antiretroviral therapy (HAART) medication regimens among HIV-positive men and women.
    Cruess DG, Minor S, Antoni MH, Millon T.
    J Pers Assess; 2007 Dec 20; 89(3):277-90. PubMed ID: 18001228
    [Abstract] [Full Text] [Related]

  • 15. Measuring HIV treatment adherence in clinical practice.
    Hecht FM.
    AIDS Clin Care; 1998 Aug 20; 10(8):57-9. PubMed ID: 11365682
    [Abstract] [Full Text] [Related]

  • 16. Objective adherence monitoring in multiple sclerosis: initial validation and association with self-report.
    Bruce JM, Hancock LM, Lynch SG.
    Mult Scler; 2010 Jan 20; 16(1):112-20. PubMed ID: 19995835
    [Abstract] [Full Text] [Related]

  • 17. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
    Kerr T, Palepu A, Barness G, Walsh J, Hogg R, Montaner J, Tyndall M, Wood E.
    Antivir Ther; 2004 Jun 20; 9(3):407-14. PubMed ID: 15259903
    [Abstract] [Full Text] [Related]

  • 18. Determinants of adherence to highly active antiretroviral therapy among HIV-1-infected patients in Côte d'Ivoire.
    Diabaté S, Alary M, Koffi CK.
    AIDS; 2007 Aug 20; 21(13):1799-803. PubMed ID: 17690579
    [Abstract] [Full Text] [Related]

  • 19. Literacy, self-efficacy, and HIV medication adherence.
    Wolf MS, Davis TC, Osborn CY, Skripkauskas S, Bennett CL, Makoul G.
    Patient Educ Couns; 2007 Feb 20; 65(2):253-60. PubMed ID: 17118617
    [Abstract] [Full Text] [Related]

  • 20. Antiretroviral treatment adherence and its correlates in Addis Ababa, Ethiopia.
    Tadios Y, Davey G.
    Ethiop Med J; 2006 Jul 20; 44(3):237-44. PubMed ID: 17447389
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.